{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T06:51:38Z","timestamp":1763967098100},"reference-count":98,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.pt.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T15:33:37Z","timestamp":1416238417000},"page":"562-570","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Neglected tools for neglected diseases: mathematical models in economic evaluations"],"prefix":"10.1016","volume":"30","author":[{"given":"Hugo C.","family":"Turner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"French","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isobel M.","family":"Blake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Churcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Gloria","family":"Bas\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2014.10.001_bib0005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases","volume":"357","author":"Hotez","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pt.2014.10.001_bib0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(06)68213-5","article-title":"The Lancet's chronic diseases series","volume":"367","author":"Hotez","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2014.10.001_bib0015","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The Global Burden of Disease Study 2010: implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0020","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1371\/journal.pmed.0030102","article-title":"Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV\/AIDS, tuberculosis, and malaria","volume":"3","author":"Hotez","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.pt.2014.10.001_bib0025","unstructured":"London Declaration on Neglected Tropical Diseases (2103) Ending the neglect and reaching 2020 goals.(http:\/\/unitingtocombatntds.org\/downloads\/press\/ntd_event_london_declaration_on_ntds.pdf)"},{"key":"10.1016\/j.pt.2014.10.001_bib0030","series-title":"Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases \u2013 A Roadmap for Implementation","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.pt.2014.10.001_bib0035","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(06)68440-7","article-title":"Advancement of global health: key messages from the Disease Control Priorities Project","volume":"367","author":"Laxminarayan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2014.10.001_bib0040","series-title":"Disease Control Priorities in Developing Countries","author":"Jamison","year":"2006"},{"key":"10.1016\/j.pt.2014.10.001_bib0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1524-4733.2003.00234.x","article-title":"Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices \u2013 modeling studies","volume":"6","author":"Weinstein","year":"2003","journal-title":"Value Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hec.1485","article-title":"Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic","volume":"19","author":"Lugner","year":"2010","journal-title":"Health Econ."},{"key":"10.1016\/j.pt.2014.10.001_bib0055","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","article-title":"Markov models in medical decision making: a practical guide","volume":"13","author":"Sonnenberg","year":"1993","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.pt.2014.10.001_bib0060","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00019053-199813040-00003","article-title":"An introduction to Markov modelling for economic evaluation","volume":"13","author":"Briggs","year":"1998","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.pt.2014.10.001_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00019053-200624040-00005","article-title":"Optimal assignment of treatments to health states using a Markov decision model: an introduction to basic concepts","volume":"24","author":"Bala","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.pt.2014.10.001_bib0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00019053-200826030-00004","article-title":"Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches","volume":"26","author":"Kim","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.pt.2014.10.001_bib0075","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1002\/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3","article-title":"Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective","volume":"18","author":"Edmunds","year":"1999","journal-title":"Stat. Med."},{"key":"10.1016\/j.pt.2014.10.001_bib0080","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.publhealth.25.102802.124353","article-title":"Modeling infection transmission","volume":"25","author":"Koopman","year":"2004","journal-title":"Annu. Rev. Public Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0085","series-title":"Infectious Diseases of Humans: Dynamics and Control","author":"Anderson","year":"1992"},{"key":"10.1016\/j.pt.2014.10.001_bib0090","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/hec.1148","article-title":"A taxonomy of model structures for economic evaluation of health technologies","volume":"15","author":"Brennan","year":"2006","journal-title":"Health Econ."},{"key":"10.1016\/j.pt.2014.10.001_bib0095","doi-asserted-by":"crossref","first-page":"e1548","DOI":"10.1371\/journal.pntd.0001548","article-title":"A research agenda for helminth diseases of humans: modelling for control and elimination","volume":"6","author":"Bas\u00e1\u00f1ez","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1473-3099(08)70099-9","article-title":"Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis","volume":"8","author":"Bas\u00e1\u00f1ez","year":"2008","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0105","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(00)04581-5","article-title":"Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment","volume":"357","author":"Hoerauf","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2014.10.001_bib0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1286-4579(03)00026-1","article-title":"Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms","volume":"5","author":"Hoerauf","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.pt.2014.10.001_bib0115","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00430-007-0062-1","article-title":"Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study","volume":"197","author":"Hoerauf","year":"2008","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.pt.2014.10.001_bib0120","series-title":"Parasitic Helminths: Targets, Screens, Drugs and Vaccines","article-title":"Ch 22 Vaccines linked to chemotherapy: a new approach to control helminth infections","author":"Lustigman","year":"2012"},{"key":"10.1016\/j.pt.2014.10.001_bib0125","series-title":"The Eradication of Infectious Diseases: Report of the Dahlem Workshop on the Eradication of Infectious Diseases","year":"1998"},{"key":"10.1016\/j.pt.2014.10.001_bib0130","first-page":"222","article-title":"Disease eradication: private versus public vaccination","volume":"87","author":"Geoffard","year":"1997","journal-title":"Am. Econ. Rev."},{"key":"10.1016\/j.pt.2014.10.001_bib0135","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1365-2656.2006.01154.x","article-title":"Density dependence and the control of helminth parasites","volume":"75","author":"Churcher","year":"2006","journal-title":"J. Anim. Ecol."},{"key":"10.1016\/j.pt.2014.10.001_bib0140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0065-308X(08)00611-8","article-title":"Onchocerca\u2013Simulium interactions and the population and evolutionary biology of Onchocerca volvulus","volume":"68","author":"Bas\u00e1\u00f1ez","year":"2009","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.pt.2014.10.001_bib0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0169-4758(88)90034-8","article-title":"Density-dependence in parasite transmission dynamics","volume":"4","author":"Dietz","year":"1988","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2014.10.001_bib0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0031182005007341","article-title":"Density dependence and overdispersion in the transmission of helminth parasites","volume":"131","author":"Churcher","year":"2005","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2014.10.001_bib0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1473-3099(05)70032-3","article-title":"Mass antibiotics for trachoma and the Allee effect","volume":"5","author":"Chidambaram","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0160","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.epidem.2011.03.004","article-title":"The epidemiological dynamics of infectious trachoma may facilitate elimination","volume":"3","author":"Lietman","year":"2011","journal-title":"Epidemics"},{"key":"10.1016\/j.pt.2014.10.001_bib0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-3156.2000.00546.x","article-title":"Economic evaluation of parasitic diseases: a critique of the internal and external validity of published studies","volume":"5","author":"Walker","year":"2000","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0170","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1371\/journal.pntd.0002027","article-title":"How effective is school-based deworming for the community-wide control of soil-transmitted helminths?","volume":"7","author":"Anderson","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1756-3305-7-266","article-title":"Can chemotherapy alone eliminate the transmission of soil transmitted helminths?","volume":"7","author":"Truscott","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.pt.2014.10.001_bib0180","doi-asserted-by":"crossref","first-page":"20130435","DOI":"10.1098\/rstb.2013.0435","article-title":"The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths","volume":"369","author":"Anderson","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.pt.2014.10.001_bib0185","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1353\/hpu.0.0270","article-title":"Neglected tropical diseases: infection, modeling, and control","volume":"21","author":"Kealey","year":"2010","journal-title":"J. Health Care Poor Underserved"},{"key":"10.1016\/j.pt.2014.10.001_bib0190","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.4269\/ajtmh.2010.09-0702","article-title":"Optimal survey designs for targeting chemotherapy against soil-transmitted helminths: effect of spatial heterogeneity and cost-efficiency of sampling","volume":"82","author":"Sturrock","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0195","article-title":"Health metrics for helminth infections","author":"King","year":"2013","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2014.10.001_bib0200","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S1473-3099(13)70002-1","article-title":"Global economic burden of Chagas disease: a computational simulation model","volume":"13","author":"Lee","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0205","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)61422-7","article-title":"Socioeconomic aspects of neglected tropical diseases","volume":"375","author":"Conteh","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pt.2014.10.001_bib0210","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1371\/journal.pntd.0000067","article-title":"National mass drug administration costs for lymphatic filariasis elimination","volume":"1","author":"Goldman","year":"2007","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0215","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.actatropica.2014.03.017","article-title":"Lymphatic filariasis and onchocerciasis prevention, treatment, and control costs across diverse settings: a systematic review","volume":"135","author":"Keating","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2014.10.001_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/heapol\/czi001","article-title":"Costs of scaling up health interventions: a systematic review","volume":"20","author":"Johns","year":"2005","journal-title":"Health Policy Plan."},{"key":"10.1016\/j.pt.2014.10.001_bib0225","doi-asserted-by":"crossref","unstructured":"Walker, D.G. and Lupp, J. (2011) Guide for preparing an eradication investment case.(http:\/\/eic-guidelines.org\/)","DOI":"10.7551\/mitpress\/9780262016735.003.0011"},{"key":"10.1016\/j.pt.2014.10.001_bib0230","doi-asserted-by":"crossref","first-page":"e2446","DOI":"10.1371\/journal.pntd.0002446","article-title":"Developing eradication investment cases for onchocerciasis, lymphatic filariasis, and human African trypanosomiasis: rationale and main challenges","volume":"7","author":"Tediosi","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2334-11-191","article-title":"Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites","volume":"11","author":"Koukounari","year":"2011","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0240","first-page":"481","article-title":"Quantifying disability: data, methods and results","volume":"72","author":"Murray","year":"1994","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.pt.2014.10.001_bib0245","first-page":"296","article-title":"Selection of MDT strategies through epidemiometric modeling","volume":"58","author":"Lechat","year":"1990","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0250","first-page":"14","article-title":"Application of an economic model to the study of leprosy control costs","volume":"46","author":"Lechat","year":"1978","journal-title":"Int. J. Lepr. Other Mycobact. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0255","doi-asserted-by":"crossref","first-page":"e708","DOI":"10.1371\/journal.pntd.0000708","article-title":"The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007)","volume":"4","author":"Chu","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0260","doi-asserted-by":"crossref","first-page":"e2936","DOI":"10.1371\/journal.pone.0002936","article-title":"Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes","volume":"3","author":"Michael","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pt.2014.10.001_bib0265","doi-asserted-by":"crossref","first-page":"e1984","DOI":"10.1371\/journal.pntd.0001984","article-title":"Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis","volume":"7","author":"Stolk","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0270","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1136\/bmj.e615","article-title":"Cost effectiveness of strategies to combat vision and hearing loss in sub-Saharan Africa and South East Asia: mathematical modelling study","volume":"344","author":"Baltussen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.pt.2014.10.001_bib0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09286580590932761","article-title":"Cost-effectiveness of trachoma control in seven world regions","volume":"12","author":"Baltussen","year":"2005","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.pt.2014.10.001_bib0280","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.vaccine.2003.08.038","article-title":"Modeling the economic net benefit of a potential vaccination program against ocular infection with Chlamydia trachomatis","volume":"22","author":"Frick","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2014.10.001_bib0285","doi-asserted-by":"crossref","first-page":"e862","DOI":"10.1371\/journal.pntd.0000862","article-title":"Targeting antibiotics to households for trachoma control","volume":"4","author":"Blake","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0290","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2458-8-96","article-title":"Estimating the burden of rhodesiense sleeping sickness during an outbreak in Serere, eastern Uganda","volume":"8","author":"F\u00e8vre","year":"2008","journal-title":"BMC Public Health"},{"issue":"I\u2013VI","key":"10.1016\/j.pt.2014.10.001_bib0295","first-page":"1","article-title":"Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee","volume":"881","author":"World Health Organization","year":"1998","journal-title":"World Health Organ. Tech. Rep. Ser."},{"key":"10.1016\/j.pt.2014.10.001_bib0300","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-3156.2005.01391.x","article-title":"The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense","volume":"10","author":"Lutumba","year":"2005","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0305","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hec.4730040404","article-title":"Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda","volume":"4","author":"Politi","year":"1995","journal-title":"Health Econ."},{"issue":"Suppl. 1","key":"10.1016\/j.pt.2014.10.001_bib0310","first-page":"237","article-title":"Comparative analysis of the costs and benefits of alternative disease control strategies: vector control versus human case finding and treatment","volume":"69","author":"Shaw","year":"1989","journal-title":"Ann. Soc. Belg. Med. Trop."},{"key":"10.1016\/j.pt.2014.10.001_bib0315","first-page":"149","article-title":"Cost and effectiveness of different approaches to schistosomiasis control in Africa","volume":"37","author":"Korte","year":"1986","journal-title":"Trop. Med. Parasitol."},{"issue":"3\u20134","key":"10.1016\/j.pt.2014.10.001_bib0320","first-page":"5","article-title":"A cost-benefit analysis of preventive schistosomiasis interventions in Kenya","volume":"7","author":"Kirigia","year":"2000","journal-title":"Afr. J. Health Sci."},{"key":"10.1016\/j.pt.2014.10.001_bib0325","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0001-706X(95)91938-5","article-title":"Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis","volume":"59","author":"Guyatt","year":"1995","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2014.10.001_bib0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0169-4758(87)90093-7","article-title":"The economics of schistosomiasis chemotherapy","volume":"3","author":"Prescott","year":"1987","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.pt.2014.10.001_bib0335","first-page":"A47","article-title":"Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine","volume":"2","author":"Evans","year":"1997","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0340","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1371\/journal.pntd.0001321","article-title":"Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review","volume":"5","author":"King","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0345","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.1221396110","article-title":"Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa","volume":"110","author":"Ndeffo Mbah","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2014.10.001_bib0350","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4269\/ajtmh.1977.26.505","article-title":"Development and verification of a schistosomiasis transmission model","volume":"26","author":"Rosenfield","year":"1977","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0355","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-3156.1998.00248.x","article-title":"An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model","volume":"3","author":"Guyatt","year":"1998","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0360","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S0031182099006101","article-title":"A population dynamic approach to evaluating the impact of school attendance on the unit cost and effectiveness of school-based schistosomiasis chemotherapy programmes","volume":"121","author":"Carabin","year":"2000","journal-title":"Parasitology"},{"key":"10.1016\/j.pt.2014.10.001_bib0365","doi-asserted-by":"crossref","first-page":"e2346","DOI":"10.1371\/journal.pntd.0002346","article-title":"Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa \u2013 the case of Zimbabwean women","volume":"7","author":"Ndeffo Mbah","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0370","doi-asserted-by":"crossref","first-page":"e1903","DOI":"10.1371\/journal.pntd.0001903","article-title":"Projecting the long-term impact of school- or community-based mass-treatment interventions for control of Schistosoma infection","volume":"6","author":"Wang","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.pt.2014.10.001_bib0375","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S0074-02761998000700010","article-title":"Different approaches to modelling the cost-effectiveness of schistosomiasis control","volume":"93","author":"Guyatt","year":"1998","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.pt.2014.10.001_bib0380","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/cid\/ciu467","article-title":"Reaching the London Declaration on Neglected Tropical Diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa","volume":"59","author":"Turner","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0385","doi-asserted-by":"crossref","first-page":"e2032","DOI":"10.1371\/journal.pntd.0002032","article-title":"African Programme for Onchocerciasis Control 1995-2015: model-estimated health impact and cost","volume":"7","author":"Coffeng","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0390","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.vaccine.2010.12.004","article-title":"The potential economic value of a hookworm vaccine","volume":"29","author":"Lee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.pt.2014.10.001_bib0395","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0035-9203(95)90638-X","article-title":"Control of Ascaris infection by chemotherapy: which is the most cost-effective option?","volume":"89","author":"Guyatt","year":"1995","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0400","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0035-9203(93)90094-7","article-title":"A population dynamic approach to the cost-effectiveness analysis of mass anthelmintic treatment: effects of treatment frequency on Ascaris infection","volume":"87","author":"Guyatt","year":"1993","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0405","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4161\/hv.20966","article-title":"Modeling the economic value of a Chagas\u2019 disease therapeutic vaccine","volume":"8","author":"Lee","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.pt.2014.10.001_bib0410","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.actatropica.2011.02.012","article-title":"Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area","volume":"118","author":"Sicuri","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.pt.2014.10.001_bib0415","doi-asserted-by":"crossref","first-page":"e916","DOI":"10.1371\/journal.pntd.0000916","article-title":"The potential economic value of a Trypanosoma cruzi (Chagas disease) vaccine in Latin America","volume":"4","author":"Lee","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0420","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/j.1537-2995.2010.02704.x","article-title":"The cost-effectiveness of pathogen reduction technology as assessed using a multiple risk reduction model","volume":"50","author":"Custer","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.pt.2014.10.001_bib0425","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/j.1537-2995.2010.02686.x","article-title":"Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi","volume":"50","author":"Agapova","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.pt.2014.10.001_bib0430","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1371\/journal.pntd.0000363","article-title":"Cost-effectiveness of Chagas disease vector control strategies in Northwestern Argentina","volume":"3","author":"Vazquez-Prokopec","year":"2009","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0435","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.2008.79.53","article-title":"Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks","volume":"79","author":"Wilson","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0440","doi-asserted-by":"crossref","first-page":"901","DOI":"10.4269\/ajtmh.2005.73.901","article-title":"Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Markov models","volume":"73","author":"Wilson","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0445","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0074-02761991000300002","article-title":"A cost-benefit analysis of Chagas disease control","volume":"86","author":"Schofield","year":"1991","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.pt.2014.10.001_bib0450","doi-asserted-by":"crossref","first-page":"e1045","DOI":"10.1371\/journal.pntd.0001045","article-title":"Evaluation of spatially targeted strategies to control non-domiciliated Triatoma dimidiata vector of Chagas disease","volume":"5","author":"Barbu","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0455","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jhealeco.2007.04.005","article-title":"Modelling geographic variation in the cost-effectiveness of control policies for infectious vector diseases: the example of Chagas disease","volume":"27","author":"Castillo-Riquelme","year":"2008","journal-title":"J. Health Econ."},{"key":"10.1016\/j.pt.2014.10.001_bib0460","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0035-9203(98)90720-9","article-title":"A cost-benefit analysis of Chagas disease control in north-western Argentina","volume":"92","author":"Basombrio","year":"1998","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0465","doi-asserted-by":"crossref","first-page":"e818","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"Meheus","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.pt.2014.10.001_bib0470","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","article-title":"Drug policy for visceral leishmaniasis: a cost-effectiveness analysis","volume":"12","author":"Vanlerberghe","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0475","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1365-3156.2002.00959.x","article-title":"How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis","volume":"7","author":"Boelaert","year":"2002","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.pt.2014.10.001_bib0480","first-page":"667","article-title":"Cost-effectiveness of competing diagnostic\u2013therapeutic strategies for visceral leishmaniasis","volume":"77","author":"Boelaert","year":"1999","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.pt.2014.10.001_bib0485","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4269\/ajtmh.2012.10-0415","article-title":"The economic value of a visceral leishmaniasis vaccine in Bihar state, India","volume":"86","author":"Lee","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.pt.2014.10.001_bib0490","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0025-5564(77)90030-X","article-title":"Togetherness among schistosomes: its effects on the dynamics of the infection","volume":"35","author":"May","year":"1977","journal-title":"Math. Biosci."}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492214001640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492214001640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T03:39:17Z","timestamp":1717558757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492214001640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":98,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S1471492214001640"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2014.10.001","relation":{},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neglected tools for neglected diseases: mathematical models in economic evaluations","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}